Deutsche Bank’s Acer Therapeutics Inc ACER Stock Holding History

Deutsche Bank’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,400	Closed	-$43K	–	4477
2020 Q2	$43K	Sell	12,400 -66	-0.5%	-$186	﹤0.01%	3884
2020 Q1	$25K	Sell	12,466 -102	-0.8%	-$374	﹤0.01%	3854
2019 Q4	$49K	Buy	12,568 +11,253	+856%	+$38.2K	﹤0.01%	3987
2019 Q3	$4K	Sell	1,315 -2,464	-65%	-$7.22K	﹤0.01%	4711
2019 Q2	$14K	Sell	3,779 -5,576	-60%	-$106K	﹤0.01%	4900
2019 Q1	$226K	Buy	9,355 +8,555	+1,069%	+$202K	﹤0.01%	3932
2018 Q4	$16K	Buy	+800	New	+$18.4K	﹤0.01%	4787
2017 Q3	–	Sell	-77	Closed	–	–	5153
2017 Q2	$0	Hold	77	–	–	﹤0.01%	5180
2017 Q1	$0	Sell	77 -6,043	-99%	-$59.5K	﹤0.01%	5159
2016 Q4	$58K	Buy	+6,120	New	+$107K	﹤0.01%	4314
2016 Q3	–	Hold	0	–	–	–	5274
2016 Q2	–	Hold	0	–	–	–	5394
2016 Q1	–	Hold	0	–	–	–	5389
2015 Q4	–	Hold	0	–	–	–	5459
2013 Q3	–	Sell	-82	Closed	-$10K	–	5787
2013 Q2	$10K	Buy	+82	New	+$12K	﹤0.01%	4920

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank's ACER Position: Q3 2020 in Review

Deutsche Bank sold out of Acer Therapeutics Inc (ACER) in Q3 2020, closing a stake of 12,400 shares — an estimated $43K sold.

Deutsche Bank first reported a position in ACER in Q2 2013 and held it in 11 quarters. The position peaked at $226K in Q1 2019. 27 funds tracked by Wall St. Rank hold ACER as of Q3 2020.

Deutsche Bank reported no remaining Acer Therapeutics Inc position as of Q3 2020 after selling out during the quarter.
Deutsche Bank sold 12,400 Acer Therapeutics Inc shares in Q3 2020, an estimated $43K.
Deutsche Bank first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 11 quarters.
Deutsche Bank's Acer Therapeutics Inc position peaked at $226K in Q1 2019.
27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.